1
Sep 2026
BeOne Medicines announces voluntary agreement with U.S. Government to expand access to innovative cancer medicines
BeOne Medicines, Ltd., a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale.